Neurodevelopmental Follow-up and Outcomes Research

The mission of the Neurodevelopmental Follow-Up and Outcomes Research group is to improve the quality of life of high-risk infants, particularly those born prematurely, and their families. The group also has a growing research interest in congenital heart disease and global child health. The group's research studies span two core themes:

  1. Develop a better understanding of long-term neurodevelopmental outcomes of high-risk infants.
  2. Discover the independent and interrelated roles of neurological and social processes underlying these neurodevelopmental outcomes.

The Neurodevelopmental Follow-Up and Outcomes Research group employs a range of methods in its studies including neurodevelopmental assessments, neuroimaging, parent and teacher reports, surveys and meta-analyses. The group also maintains collaboration with researchers at Harvard Medical School, Boston, USA; The Ohio State University College of Medicine, Columbus, USA; University of Canterbury, Christchurch, New Zealand; University of Cincinnati College of Medicine, Cincinnati, USA; University of Ghana Medical School, Accra, Ghana; University of Otago, Christchurch, New Zealand and Washington University School of Medicine, St. Louis, USA.

Group Members:

  • Mr Benjamin Austin, PhD Candidate
  • Ms Emma Sanders, Clinical Research Psychologist
  • Mr Gautam Dagur, MD-PhD Candidate
  • Ms Georgia Morris, Honours Candidate
  • Ms Jemima Walker, Clinical Research Coordinator
  • Ms Karen Eagleson, PhD Candidate
  • Ms Victoria Gill, MD-PhD Candidate

 

Group Leaders